The circular RNA circINPP4B acts as a sponge of miR-30a to regulate Th17 cell differentiation during progression of experimental autoimmune encephalomyelitis

被引:0
作者
Jingjing Han
Wei Zhuang
Wanhua Feng
Fuxing Dong
Fang Hua
Ruiqin Yao
Xuebin Qu
机构
[1] Xuzhou Medical University,Department of Cell Biology and Neurobiology, Xuzhou Key Laboratory of Neurobiology
[2] Affiliated Hospital of Xuzhou Medical University,Department of Neurology
[3] Tongji University,Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology
[4] Institute of Neurological Diseases of Xuzhou Medical University,undefined
来源
Cellular & Molecular Immunology | 2021年 / 18卷
关键词
Circular RNA; Multiple sclerosis; Experimental autoimmune encephalomyelitis; T helper cell; miR-30a;
D O I
暂无
中图分类号
学科分类号
摘要
Circular RNAs (circRNAs) regulate gene expression and participate in various biological and pathological processes. However, little is known about the effects of specific circRNAs on T helper cell 17 (Th17) differentiation and related autoimmune diseases, such as multiple sclerosis (MS). Here, using transcriptome microarray analysis at different stages of experimental autoimmune encephalomyelitis (EAE), we identified the EAE progression-related circINPP4B, which showed upregulated expression in Th17 cells from mice with EAE and during Th17 differentiation in vitro. Silencing of circINPP4B inhibited Th17 differentiation and alleviated EAE, characterized by less demyelination and Th17 infiltration in the spinal cord. Mechanistically, circINPP4B served as a sponge that directly targeted miR-30a to regulate Th17 differentiation. Furthermore, circINPP4B levels were associated with the developing phases of clinical relapsing-remitting MS patients. Our results indicate that circINPP4B plays an important role in promoting Th17 differentiation and progression of EAE by targeting miR-30a, which provides a potential diagnostic and therapeutic target for Th17-mediated MS.
引用
收藏
页码:2177 / 2187
页数:10
相关论文
共 233 条
  • [1] Dolati S(2017)Multiple sclerosis: therapeutic applications of advancing drug delivery systems Biomed Pharmacother 86 343-53
  • [2] Babaloo Z(2012)Pathology of demyelinating diseases Annu Rev Pathol. 7 185-217
  • [3] Jadidi-Niaragh F(2014)The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis Mult Scler Int. 2014 285245-226
  • [4] Ayromlou H(2021)The Ins and Outs of Central Nervous System Inflammation-Lessons Learned from Multiple Sclerosis Annu Rev Immunol. 39 199-901
  • [5] Sadreddini S(2013)[Immunology for understanding the pathogenesis of multiple sclerosis] Rinsho Shinkeigaku 53 898-41
  • [6] Yousefi M(2020)The role of TH17 cells in multiple sclerosis: therapeutic implications Autoimmun Rev. 19 102647-34
  • [7] Popescu BF(2019)TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development J Neuroinflammation 16 3329-8
  • [8] Lucchinetti CF(2009)Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis Brain: J Neurol. 132 329-90
  • [9] Duffy SS(2007)The function of interleukin 17 in the pathogenesis of rheumatoid arthritis Arch Immunol Ther Exp (Warsz.) 55 382-9
  • [10] Lees JG(2018)Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation Front Immunol. 9 88-44